2017 BioAmber Inc. All Rights Reserved. CORPORATE OVERVIEW

Transcription

1 2017 BioAmber Inc. All Rights Reserved. CORPORATE OVERVIEW

2 SAFE HARBOR STATEMENT Forward-Looking Statements. This presentation contains express or implied forward-looking statements, which are based on current expectations of management. These statements relate to, among other things, our expectations regarding management s plans, objectives, and strategies. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, any projections of financial information; any statements about historical results that may suggest trends for our business and results of operations; any statements of the plans, strategies and objectives of management for future operations, including the timing, funding and construction of planned manufacturing facilities; any statements of expectation or belief regarding future events, potential markets or applications, the sizes of addressable markets, expected technology developments, strategic partnerships and collaborations, or enforceability of our intellectual property rights; any statements about the projected or expected economic or other benefits of our products compared to petroleum-derived equivalents, future sales and any statements of assumptions underlying any of the foregoing. Forward-looking statements are subject to a number of risks, assumptions and uncertainties, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in periodic reports filed with the Securities and Exchange Commission (SEC), as well as other documents that may be filed by us from time to time with the SEC. In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the expected funding sources of our future manufacturing facilities and the expected timing of the construction and the start of commercial operations of of these facilities; our joint venture with Mitsui & Co. Ltd; our offtake agreements with Vinmar International Ltd, related to bio-based 1, 4 BDO and bio-succinic acid, and with PTTMCC Biochem for bio-succinic acid; the expected applications of our products and the sizes of addressable markets; our ability to gain market acceptance for bio-succinic acid, its derivatives and other building block chemicals; the benefits of our yeast; our ability to ramp up commercial sales and execute on our commercial expansion plan, including the timing, volume and margins of our future production and sales; the expected cost-competitiveness and relative performance attributes of our bio-succinic acid and the products derived from it; our ability to cost-effectively produce and commercialize bio-succinic acid, 1,4-BDO and THF; customer qualification, approval and acceptance of our products; our ability to maintain and advance strategic partnerships and collaborations and the expected benefits and accessible markets related to those partnerships and collaborations; the impact of our off-take agreements on our business with our customers, our distributors and our current and future equity partners; our ability to economically obtain feedstock and other inputs; the achievement of advances in our technology platform; our ability to obtain and maintain intellectual property protection for our products and processes and not infringe on others' rights; government regulatory and industry certification approvals for our facilities and products; government policymaking and incentives relating to bio-chemicals; and the other factors listed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 and Form 10-Q for the quarter ended September 30, Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the events and circumstances reflected in the forward-looking statements will be achieved or occur and the timing of events and circumstances and actual results could differ materially from those projected in the forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Before you invest, you should read the documents the issuer has filed with the SEC for more complete information about the Company. You may get these documents for free by visiting EDGAR on the SEC Web site at Trademarks. Our trademarks may not be copied, imitated or used, in whole or in part, without our prior written permission. Other trademarks, registered trademarks or logos, company names or logos displayed in this presentation are the property of their owners BioAmber Inc. All Rights Reserved. 2

3 CORPORATE PROFILE Ticker : Listing BIOA : NYSE Founded 2008 Employees Company Description Analyst Coverage Shares Outstanding 90 (including 60 in production facility) Renewable materials company: produce biosuccinic acid, a building block chemical, using agricultural feedstock AltaCorp, Barclays, Canaccord, Rodman & Renshaw million 2017 BioAmber Inc. All Rights Reserved. 3

4 BIOAMBER IS A PRODUCER OF BIO-SUCCINIC ACID STRONG IP portfolio: Best in class yeast licensed from Cargill Patents and trade secrets for commercial design INNOVATIVE biotechnology Disruptive cost structure vs. petrochemical process Business model does not rely on subsidies FIRST MOVER advantage: World s largest succinic acid manufacturing facility Track record of delivering on important milestones 2017 BioAmber Inc. All Rights Reserved. 4

5 BIO-SUCCINIC ACID: USED IN MANY APPLICATIONS Paints & Coatings Plastics Polyurethanes Corrosion inhibitors & Coolants Better impact and UV resistance Biodegradability Improved durability and aesthetics Improved corrosion inhibition Plasticizers PET Additives Personal Care Foods & Flavors Better mechanical properties Faster processing and lower cost All natural, less irritating ph control & flavor enhancement BioAmber has generated extensive data demonstrating these performance benefits 2017 BioAmber Inc. All Rights Reserved. 5

6 A MORE SUSTAINABLE CARBON FOOTPRINT Our Sarnia Facility s Environmental Profile Our Sarnia Facility s Impact GHG emissions of 45,000 cars / year 5.6M tree seedlings growing for 10 years Field-to-Gate Energy and Greenhouse Gas Emissions Associated with Succinic Acid Produced At BioAmber s Facility In Sarnia Ontario, Canada 508,000 barrels of oil consumed / year Electricity use of 46,000 homes / year 2017 BioAmber Inc. All Rights Reserved. 6

7 FIRST PLANT IN OPERATION, SALES RAMPING Commercial plant started production in October 2015 Over 180 companies globally have qualified our succinic acid Succinic Acid Sales (millions) $4.0 $3.5 $3.0 Quarter over quarter growth rate > 48% $2.5 $3.7 $2.5 $2.0 $1.5 $1.0 $1.1 $1.5 Plant #1 (Sarnia) Nameplate Capacity: 30,000 MT / year of SA World s Largest SA plant is a Joint Venture 60% BioAmber, 40% Mitsui & Co. $0.5 $ Q Q Q Q BioAmber Inc. All Rights Reserved. 7

8 SUCCINIC ACID (SA): A BUILDING BLOCK CHEMICAL SA is among top 12 value added chemicals from biomass identified by the US DOE New SA Markets plastics, foods, corrosion inhib. SA can be converted into many other chemicals * Replace Petro SA personal care, inks, pharma * Bio SA Replace Adipic Acid Replace Isophthalic polyurethanes, paints/coatings UPR, PET Convert to BDO / THF various uses (see next page) Source: U.S. Department of Energy - Energy Efficiency and Renewable Energy Top Value Added Chemicals from Biomass (2004) Convert to Ester/Other lubricants, solvents, other 2017 BioAmber Inc. All Rights Reserved. 8

9 BDO & THF: LARGE, EXISTING DROP-IN MARKETS Bio-based 1,4-Butanediol (BDO)* $4.0 Billion market Plastics Polyurethanes BDO/THF Market Expected BioAmber capacity: 94,000 MT 4% Bio-based Tetrahydrofuran (THF)* $2.0 Billion market * Market sizes are estimates based on 10 year average prices Spandex & Polyesters BDO/THF market 2,400,000 MT BDO market projected to grow at 6.5% CAGR between 2012 and 2025 Sources: Technon Orbichem 2014, ChembizR 2015, IHS BioAmber Inc. All Rights Reserved. 9

10 PLANT 2: PROVEN TECHNOLOGY WITH OFFTAKE Proven Technology 60,000 MT SA 70,000 MT BDO 24,000 MT THF 200,000 MT SA 14 licensed BDO/THF plants built globally Long-Term Offtake Profile Large Houston based company Global marketer of chemicals/plastics Principal offtaker of Saudi BDO plant Offtake Commitment* 70,0000 MT / year BDO 24,000 MT / year THF * Offtake commitments subject to financial close and construction of plant, SA capacity and volume to be agreed prior to financial close Potential Value** 15 year contract ~$5 Billion cumulative sales over life of contract ** Calculated as follows: off-take volume X contract duration X historical 10 year average selling prices : $1.00 / lb for SA and BDO, $1.35 / lb for THF 2017 BioAmber Inc. All Rights Reserved. 10

11 PLANT 2: TARGETING PROJECT LEVEL DEBT Potential Government Support Would Limit Equity Investment US DOE Loan Guarantee Process BioAmber $360 million application is in phase 3 of DOE process 30% 70% Source: US Department of Energy Loan Programs Office BioAmber Project Meets DOE Eligibility Criteria Strong economics and the ability to repay the loan Creation of 154 advanced manufacturing jobs and over 600 construction jobs First deployment of technology in United States Significant reduction in greenhouse gases vs. petro DOE Loan Guarantee has an interest rate equal to treasury rate plus 0.5 to 1.5% credit-based spread Low Interest Loan Equity Timeline for Plant 2 Funding Q2 2017: finalize project debt Q3 2017: secure equity partners Q4 2017: achieve a financial close A parallel process is being run with agencies in Canada with same timeline 2017 BioAmber Inc. All Rights Reserved. 11

12 BIOAMBER S VISION FOR GROWTH Plant 2 Would Deliver Transformational Growth Plant 2 Sarnia Revenues (US$) $60,000,00 0 $360,000,0 00 Planned Equity Partners Vinmar (offtaker): 10% Other partners: 10% to 39% Strategic partners Financial partners BioAmber: 51% to 80% Plant 2 EBITDA (US$) $145,000, 000 BioAmber Contributions Rights to proven technologies Government support/incentives Off-take agreements Sarnia $24,000,0 00 BioAmber will seek to monetize these contributions 2017 BioAmber Inc. All Rights Reserved. 12

13 CHINA JV: POTENTIAL GROWTH ACCELERATION Proposed Structure KEY FACTS 36,000 MT of initial capacity Start up target date is Q CJCJ Provides 100% of the capital needed to start-up plant CJCJ takes the lead in producing and selling bio-sa Benefits of Proposed JV CJ CheilJedang (CJCJ) is a world leader in fermentation CJ is a proven operator with facilities on six continents JV would be lowest cost producer of succinic acid in China BIOA receives a royalty on sales BIOA receives 35% of JV profits BIOA and CJ have mutual right of first refusal on future retrofits 2017 BioAmber Inc. All Rights Reserved. 13

14 EXPERIENCED MANAGEMENT TEAM Jean-Francois Huc Mario Saucier Fabrice Orecchioni James Millis Chief Executive Officer Chief Financial Officer Chief Operations Officer Chief Technology Officer Chris Ellen VP Commercial Roy McDowall Sr. VP Communication & Strategy Mike Hartmann Executive VP, co-founder EMPLOYEE AND BOARD EXPERTISE FROM FERMENTATION & CHEMICAL INDUSTRIES 2017 BioAmber Inc. All Rights Reserved. 14

15 BioAmber Inc Rene Levesque Blvd West, Suite 4310 Montreal (Quebec) Canada H3B 4W8 Contact info Roy McDowall, Sr. VP Communication & Strategy w: extension BioAmber Inc. All Rights Reserved. 15